2016, Volume 23, Supplement 2: The future of cardioversion management – new strategies for the use of oral anticoagulation in direct current cardioversion

Introduction

November 2016 Br J Cardiol 2016;23(suppl 2):S1–S12

Introduction

Multiple clinical risk factors, electrocardiographic/echocardiographic features and biochemical markers are associated with an increased risk of atrial fibrillation (AF). AF poses a significant challenge from...
Direct current cardioversion and thromboprophylaxis in atrial fibrillation

November 2016 Br J Cardiol 2016;23(suppl 2):S1–S12

Direct current cardioversion and thromboprophylaxis in atrial fibrillation

Atrial fibrillation (AF) is the most common type of sustained cardiac arrhythmia, with an overall prevalence in the UK of 1.6% in women and 2.4%...